Report Overview
The global Human Serum Albumin market was valued at 5822 million in 2024 and is projected to reach US$ 9240 million by 2031, at a CAGR of 7.0% during the forecast period.
Human Serum Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The human serum albumin (HSA) market is driven by the increasing prevalence of liver diseases, nephrotic syndrome, and hypoalbuminemia, which require albumin-based therapies. Additionally, HSA is widely used in critical care settings for treating burns, shock, and surgical recovery, boosting its demand. The expanding applications of albumin in biopharmaceuticals, including drug delivery, vaccine formulation, and regenerative medicine, further fuel market growth. Rising healthcare expenditures, improvements in plasma collection infrastructure, and growing demand in emerging markets like China and India contribute to the industrys expansion.
However, the market faces challenges such as limited plasma supply and high production costs, as HSA is primarily derived from human plasma, which is subject to stringent donation regulations. Stringent government policies and safety concerns regarding pathogen transmission also hinder market growth. Additionally, competition from synthetic and recombinant HSA (rHSA) is increasing, though high production costs and market acceptance remain barriers. Overcoming supply chain constraints and advancing rHSA technologies will be crucial for sustaining growth in the global HSA market.
The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%.
Prospect Research Reports (PRR) has surveyed the Human Serum Albumin manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Serum Albumin. This report contains market size and forecasts of Human Serum Albumin in global, including the following market information:
Global Human Serum Albumin market revenue, 2020-2025, 2026-2031, ($ millions)
Global Human Serum Albumin market sales, 2020-2025, 2026-2031, (MT)
Global top five Human Serum Albumin companies in 2024 (%)
Total Market by Segment:
Global Human Serum Albumin market, by Type, 2020-2025, 2026-2031 ($ millions) & (MT)
Global Human Serum Albumin market segment percentages, by Type, 2024 (%)
20-25% Concentrations
5% Concentrations
Global Human Serum Albumin market, by Application, 2020-2025, 2026-2031 ($ Millions) & (MT)
Global Human Serum Albumin market segment percentages, by Application, 2024 (%)
Therapeutics
Excipient
Other
Global Human Serum Albumin market, by region and country, 2020-2025, 2026-2031 ($ millions) & (MT)
Global Human Serum Albumin market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Serum Albumin revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Human Serum Albumin revenues share in global market, 2024 (%)
Key companies Human Serum Albumin sales in global market, 2020-2025 (estimated), (MT)
Key companies Human Serum Albumin sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Weiguang Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Serum Albumin, market overview.
Chapter 2: Global Human Serum Albumin market size in revenue and volume.
Chapter 3: Detailed analysis of Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Serum Albumin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
